Similar articles

• On "Current role of antithrombotic agents in the treatment of acute coronary syndromes" (Semin Thromb Hemost 2004;30:627-632).

  Nessel CO. Nessel CO. Semin Thromb Hemost. 2005 Apr;31(2):248. doi: 10.1055/s-2005-869530. Semin Thromb Hemost. 2005. PMID: 15852228 No abstract available.
• Coronary thrombolysis: hemorrhagic complications.

  Hirsh J. Hirsh J. Can J Cardiol. 1993 Jul-Aug;9(6):505-11. Can J Cardiol. 1993. PMID: 8221344 Review. No abstract available.
• Aspirin after thrombolysis for MI.

  Seaton TL. Seaton TL. J Fam Pract. 1997 Mar;44(3):249-50. J Fam Pract. 1997. PMID: 9071241 No abstract available.
• Substitution of fractionated for unfractionated heparin during high-risk percutaneous coronary intervention: has the problem been solved?

  Eisenberg MJ. Eisenberg MJ. J Am Coll Cardiol. 2007 Jun 12;49(23):2247-8. doi: 10.1016/j.jacc.2007.04.006. Epub 2007 May 25. J Am Coll Cardiol. 2007. PMID: 17560288 No abstract available.
• [Anti thrombotic therapy after coronary thrombolysis].

  Tani S, Kanmatsuse K. Tani S, et al. Nihon Rinsho. 2003 Apr;61 Suppl 4:484-8. Nihon Rinsho. 2003. PMID: 12735020 Review. Japanese. No abstract available.